Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery

NCT02616315 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Weight Regain Post Bariatric Surgery

Interventions

DRUG: Naltrexone HCl/Bupropion HCl Placebo
DRUG: Naltrexone HCl/Bupropion HCl

Sponsor

Takeda